Beam Therapeutics Inc. Total liabilities

Total liabilities of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total liabilities for the quarter ending September 30, 2022 was $636 Million (a 2.84% increase compared to previous quarter)
  • Year-over-year quarterly Total liabilities decreased by -1.84%
  • Annual Total liabilities for 2021 was $648 Million (a 214.25% increase from previous year)
  • Annual Total liabilities for 2020 was $206 Million (a -42.3% decrease from previous year)
  • Annual Total liabilities for 2019 was $357 Million (a 25.59% increase from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total liabilities of Beam Therapeutics Inc.

Most recent Total liabilitiesof BEAM including historical data for past 10 years.

Interactive Chart of Total liabilities of Beam Therapeutics Inc.

Beam Therapeutics Inc. Total liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $635.77 $618.21 $624.33
2021 $647.72 $302.74 $344.53 $270.81 $647.72
2020 $206.12 $78.2 $69.15 $61.24 $206.12
2019 $357.2 $0.0 $0.0 $0.0 $357.2
2018 $284.42 $284.42
2017 $7.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology